info:eu-repo/semantics/article
An arsenic fluorescent compound as a novel probe to study arsenic-binding proteins
Date
2012-12Registration in:
Femia, Lis; Temprana, Carlos Facundo; Santos, Javier; Carbajal, Maria Laura; Amor, María Silvia; et al.; An arsenic fluorescent compound as a novel probe to study arsenic-binding proteins; Springer; Protein Journal; 31; 8; 12-2012; 656-666
1572-3887
CONICET Digital
CONICET
Author
Femia, Lis
Temprana, Carlos Facundo
Santos, Javier
Carbajal, Maria Laura
Amor, María Silvia
Grasselli, Mariano
Alonso, Silvia del Valle
Abstract
Arsenic-binding proteins are under continuous research. Their identification and the elucidation of arsenic/ protein interaction mechanisms are important because the biological effects of these complexes may be related not only to arsenic but also to the arsenic/protein structure. Although many proteins bearing a CXXC motif have been found to bind arsenic in vivo, new tools are necessary to identify new arsenic targets and allow research on protein/ arsenic complexes. In this work, we analyzed the performance of the fluorescent compound APAO-FITC (synthesized from p-aminophenylarsenoxide, APAO, and fluorescein isothiocyanate, FITC) in arsenic/protein binding assays using thioredoxin 1 (Trx) as an arsenic-binding protein model. The Trx-APAO-FITC complex was studied through different spectroscopic techniques involving UV-Vis, fluorescence, atomic absorption, infrared and circular dichroism. Our results show that APAO-FITC binds efficiently and specifically to the Trx binding site, labeling the protein fluorescently, without altering its structure and activity. In summary, we were able to study a protein/ arsenic complex model, using APAO-FITC as a labeling probe. The use of APAO-FITC in the identification of different protein and cell targets, as well as in in vivo biodistribution studies, conformational studies of arsenicbinding proteins, and studies for the design of drug delivery systems for arsenic anti-cancer therapies, is highly promising.